Search

Search Constraints

You searched for: Author/Creator Bellecave, Pantxika

Search Results

1. A Low Level of Darunavir Resistance–Associated Mutation Emergence in Patients With Virological Failure During Long-term Use of Darunavir in People With HIV. The ANRS CO3 Aquitaine Cohort. (19th November 2020)

2. Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey. (7th July 2021)

3. Feasibility of convalescent plasma therapy in severe COVID‐19 patients with persistent SARS‐CoV‐2 viremia. Issue 9 (3rd May 2021)

4. High decay of blood HIV reservoir when tenofovir/emtricitabine/elvitegravir/cobicistat is initiated during the acute primary HIV infection. (5th June 2017)

5. Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen. (8th January 2018)

6. Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients. (12th July 2019)

7. Switch to Rilpivirine/Emtricitabine/Tenofovir Single-Tablet Regimen of Human Immunodeficiency Virus-1 RNA-Suppressed Patients, Agence Nationale de Recherches sur le SIDA et les Hépatites Virales CO3 Aquitaine Cohort, 2012–2014. (1st February 2015)

8. Virological failure of patients on maraviroc-based antiretroviral therapy. (19th February 2015)